These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25724588)

  • 1. Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues.
    Huser M; Smardova L; Janku P; Crha I; Zakova J; Stourac P; Jarkovsky J; Mayer J; Ventruba P
    J Assist Reprod Genet; 2015 Aug; 32(8):1187-93. PubMed ID: 25724588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
    Blumenfeld Z; Avivi I; Eckman A; Epelbaum R; Rowe JM; Dann EJ
    Fertil Steril; 2008 Jan; 89(1):166-73. PubMed ID: 17601603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
    Behringer K; Mueller H; Goergen H; Thielen I; Eibl AD; Stumpf V; Wessels C; Wiehlpütz M; Rosenbrock J; Halbsguth T; Reiners KS; Schober T; Renno JH; von Wolff M; van der Ven K; Kuehr M; Fuchs M; Diehl V; Engert A; Borchmann P
    J Clin Oncol; 2013 Jan; 31(2):231-9. PubMed ID: 23150709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
    Behringer K; Thielen I; Mueller H; Goergen H; Eibl AD; Rosenbrock J; Halbsguth T; Eichenauer DA; Fuchs M; Reiners KS; Renno JH; van der Ven K; Kuehr M; von Wolff M; Diehl V; Engert A; Borchmann P
    Ann Oncol; 2012 Jul; 23(7):1818-25. PubMed ID: 22228451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
    Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
    Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group.
    Behringer K; Wildt L; Mueller H; Mattle V; Ganitis P; van den Hoonaard B; Ott HW; Hofer S; Pluetschow A; Diehl V; Engert A; Borchmann P;
    Ann Oncol; 2010 Oct; 21(10):2052-2060. PubMed ID: 20305034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.
    Blumenfeld Z; Evron A
    Expert Opin Pharmacother; 2015 May; 16(7):1009-20. PubMed ID: 25826240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report.
    Pereyra Pacheco B; Méndez Ribas JM; Milone G; Fernández I; Kvicala R; Mila T; Di Noto A; Contreras Ortiz O; Pavlovsky S
    Gynecol Oncol; 2001 Jun; 81(3):391-7. PubMed ID: 11371127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients.
    Nitzschke M; Raddatz J; Bohlmann MK; Stute P; Strowitzki T; von Wolff M
    Arch Gynecol Obstet; 2010 Jul; 282(1):83-8. PubMed ID: 19967405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.
    Demeestere I; Brice P; Peccatori FA; Kentos A; Dupuis J; Zachee P; Casasnovas O; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
    J Clin Oncol; 2016 Aug; 34(22):2568-74. PubMed ID: 27217453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.
    Demeestere I; Brice P; Peccatori FA; Kentos A; Gaillard I; Zachee P; Casasnovas RO; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
    J Clin Oncol; 2013 Mar; 31(7):903-9. PubMed ID: 23129737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
    Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
    Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females.
    Potolog-Nahari C; Fishman A; Cohen I
    Gynecol Endocrinol; 2007 May; 23(5):290-4. PubMed ID: 17558688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
    Blumenfeld Z
    Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility after treatment for Hodgkin's disease.
    Blumenfeld Z; Dann E; Avivi I; Epelbaum R; Rowe JM
    Ann Oncol; 2002; 13 Suppl 1():138-47. PubMed ID: 12078896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation.
    Blumenfeld Z; Patel B; Leiba R; Zuckerman T
    Fertil Steril; 2012 Nov; 98(5):1266-70.e1. PubMed ID: 22935556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal Function Recovery and Fertility in Women Treated with Chemo- and/or Radiotherapy for Hodgkin's and Non-Hodgkin Lymphoma.
    Gini G; Annibali O; Lupasco D; Bocci C; Tomarchio V; Sampaolo M; Trappolini S; Tafuri MA; Cacciagiù S; Ciccarone M; Barucca A; Sarlo C; Vincenzi B; Avvisati G; Leoni P; Olivieri A
    Chemotherapy; 2019; 64(1):36-41. PubMed ID: 31117081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
    Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review.
    Drechsel KCE; Pilon MCF; Stoutjesdijk F; Meivis S; Schoonmade LJ; Wallace WHB; van Dulmen-den Broeder E; Beishuizen A; Kaspers GJL; Broer SL; Veening MA
    Hum Reprod Update; 2023 Jul; 29(4):486-517. PubMed ID: 36779325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.